Butyrate production

Butyrate production" refers to the **microbial metabolic pathways by which certain anaerobic bacteria in the human colon convert dietary fibers and other substrates into the short-chain fatty acid** *butyric acid* (**butyrate**). This is not a single molecular target such as an enzyme or receptor, but rather a collective term for several enzymatic pathways present in various bacterial species. The main routes involve conversion from pyruvate, glutarate, 4‑aminobutyrate, or lysine through intermediates like crotonyl-CoA and ultimately yield butyryl-CoA. The final step is catalyzed by either **butyryl-CoA:acetate CoA transferase** or **butyrate kinase**, depending on the organism. Key bacterial families involved include *Lachnospiraceae* and *Ruminococcaceae*, which are abundant in the human colon. Produced **butyrate** serves as an energy source for colonic epithelial cells and exerts important regulatory functions on host physiology—including acting as an epigenetic modifier by inhibiting histone deacetylases (HDACs), activating G protein-coupled receptors FFAR2/FFAR3 on host cells, modulating inflammation via PPARγ signaling pathways, improving insulin sensitivity, reducing appetite and energy intake. Because "Butyrate production" describes a biological process rather than a discrete druggable entity like an enzyme/receptor/transporter/etc., it should not be considered a canonical therapeutic target. Instead, individual enzymes within these pathways—such as **butyryl-CoA:acetyl CoA transferase**, **phosphate-butaryl transferase**, or specific microbial taxa—could be considered targets if further specificity is required. In summary: > “Butyrate production” does not refer to one molecule/receptor/enzyme/transporter/etc., so it should not be treated as a canonical therapeutic target. It represents complex microbial metabolic processes involving multiple enzymes across diverse bacterial species that collectively generate beneficial short-chain fatty acids from dietary substrates.

Other names

Butyrate synthesisBacterial butyrate biosynthesisMicrobial butyrate formation

For drugs/interventions that affect this pathway indirectly: – Modulation of gut microbiota composition to enhance populations of butyrogenic bacteria – Dietary fiber supplementation to increase substrate availability for microbial fermentation – Use of probiotics containing known butyrogenic strains